Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase IIb global clinical trial to evaluate the safety and efficacy of AM006 in patients with early Parkinson's Disease (PD)

X
Trial Profile

A phase IIb global clinical trial to evaluate the safety and efficacy of AM006 in patients with early Parkinson's Disease (PD)

Status: Planning
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2021

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs KDT 3594 (Primary)
  • Indications Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors AffaMed Therapeutics
  • Most Recent Events

    • 02 Jun 2021 New trial record
    • 27 May 2021 According to an AffaMed Therapeutics media release, Clinical Trial Application (CTA) is approved in Singapore in April 2021.
    • 27 May 2021 According to an AffaMed Therapeutics media release, China's National Medical Products Administration (NMPA) has approved the Clinical Trial Application (CTA) for this trial.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with username/password or try via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top